OpGen, Inc. (OPGN)
OTCMKTS
· Delayed Price · Currency is USD
1.640
-0.260 (-13.68%)
Oct 25, 2024, 11:02 AM EDT
OpGen Revenue
OpGen had revenue of $28.00K in the quarter ending June 30, 2024, a decrease of -96.20%. This brings the company's revenue in the last twelve months to $1.96M, down -30.32% year-over-year. In the year 2023, OpGen had annual revenue of $3.42M with 31.11% growth.
Revenue (ttm)
1.96M
Revenue Growth
-30.32%
P/S Ratio
1.13
Revenue / Employee
21.13K
Employees
93
Market Cap
15.88M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.42M | 811.03K | 31.11% |
Dec 31, 2022 | 2.61M | -1.70M | -39.45% |
Dec 31, 2021 | 4.31M | 91.59K | 2.17% |
Dec 31, 2020 | 4.21M | 715.83K | 20.46% |
Dec 31, 2019 | 3.50M | 552.31K | 18.75% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 108.78M |